Navigation Links
Palatin Technologies Announces Reacquisition of Full Rights to Bremelanotide Program
Date:9/10/2007

further development of bremelanotide for the treatment of ED.

"Regarding the FSD program with bremelanotide, we have completed an exploratory at-home Phase 2 clinical trial in pre- and postmenopausal women and are in the final stages of compiling the data. We anticipate releasing the results later this month," stated Carl Spana, Ph.D., President and Chief Executive Officer of Palatin.

Palatin will also continue to focus its efforts on the Company's pipeline of preclinical therapeutics, including its compounds for obesity partnered with AstraZeneca and a lead clinical candidate for the treatment of congestive heart failure.

Conference Call and Webcast Access Information

Palatin Technologies' management will discuss the status of the bremelanotide program during a conference call and webcast today at 9:00 a.m. ET.

Conference Call - Live 9/10/2007 at 9:00 a.m. ET

Domestic Dial-In Number: 1-888-802-2225

International Dial-In Number: 1-913-312-1268

Conference Call - Replay 9/10/2007 - 9/17/2007

Domestic Dial-In Number: 1-888-203-1112

International Dial-In Number: 1-719-457-0820

Replay Passcode #: 6090184

The webcast and replay can be accessed by logging on to the "Investor Center-Webcasts" section of Palatin's website at http://www.palatin.com.

About ED

ED is defined as the consistent inability to attain and maintain an erection sufficient for sexual intercourse. The condition is correlated with increasing age, cardiovascular disease, hypertension, diabetes, hyperlipidemia, and smoking. In addition, certain prescription drugs and psychogenic issues may contribute to ED. It is estimated that some degree of ED affects one half of all men over the age of 40 and that 150 million men worldwide suffer from ED.

About FSD

Female sex
'/>"/>

SOURCE Palatin Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Barriers will not stop convergence of medical technologies
2. Merge Technologies net loss doubles to $10.1M
3. Making deals with evolving technologies in mind
4. Third Wave Technologies to raise $14.9M through private debt
5. Meier joins Broadlook Technologies as COO
6. Platypus Technologies secures $450K SBIR grant
7. Napier joins board of Third Wave Technologies
8. aOva Technologies raises $3 million
9. Consumer, business technologies face same challenges
10. Promega to get early access to WARF technologies under new agreement
11. Linda Weber to run Fiservs Interactive Technologies unit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)... Applied Biosystems, part of Life Technologie...ive life science research and discovery solutions,...ration genomic analysis, the SOLiD™ System, ...Year for 2008 by The Scientist, a leading scientif...y. In making the announcement of the first-ever Li...
(Date:12/3/2008)...nown dangers of first- and secondhand smoke, an es...are smokers. Exposure of a developing baby to har...ffects an estimated 420,000 newborns each year and...in the first study of its kind, a team of research... umbilical cord blood to better understand the fet...
(Date:12/3/2008)...HIA, Dec. 3 GlaxoSmithKl... waiving a condition relating to a,pending lawsui...hase all of,the outstanding shares of common stoc...), for $1.30 per share in cash without interest an...t is a condition to the completion of the tender o...
(Date:12/3/2008)...December 3 Cellectricon, a leading...ry, today announced the,signing of a collaborativ...in,the UK, manufacturers of advanced automated sy...h throughput screening applications. Under the agr...naflow(R)HT System, Cellectricon,s,next generatio...
Breaking Biology Technology: Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 2 Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 3 Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 4 Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 5Cutting the cord to determine babies' health risk from toxic exposure 2Cutting the cord to determine babies' health risk from toxic exposure 3Cutting the cord to determine babies' health risk from toxic exposure 4GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc. 2GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc. 3Cellectricon Partners With The Automation Partnership - Bringing Next Generation Ion Channel Screening System to Market. 2Cellectricon Partners With The Automation Partnership - Bringing Next Generation Ion Channel Screening System to Market. 3
...an landscape, Google is achieving a similar posi... Google,s brand and services don,t touch my life a...business owner. , ,The seven-year-old company, wh... ads, went public just 15 months ago at $85 and cl...apitalization is over $109 billion, making it the ...
...nnounced a new eHealth Care Quality and Patient Sa...n of electronic medical records in Wisconsin. , ,"... of information technology at the most important p...," Doyle said in a statement, citing statistics sh...ry or redundant. "This board will develop a road m...
...hursday his veto of AB 499, which would have outla...e bill would outlaw not only cloning for reproduct...utic or research cloning, in which an embryo is cr...r the purposes of harvesting stem cells during the...destroyed in the process. , ,Penalties for violati...
...ouncil has teamed with JobSightUSA , a top-ranked...st, to match job seekers with positions based on s...bSightUSA helps companies that are considering loc...d hire professionals, while also assisting former ... state. The site enables professional jobseekers t...
Other Biology Technology:Are you a citizen of the "Google Nation?" 2Are you a citizen of the "Google Nation?" 3Wisconsin pushes for adoption of electronic health records 2Doyle vetoes cloning ban 2
(Date:12/4/2008)...men, often touting their intelligence and their hi...g University and Oxford University that studied 40...e partners. , Research in the theory of evolutio... men and women choose their partners. Among the m...is on attractive appearance, whereas resources and...
(Date:12/3/2008)...ay, it,s easy to forget that a dam and pond stood ...n,s Franbrook Farm Research Station in southwester... and acres of plants, both native and weedy, now c...ess, memories of the dam remain, and by digging in...are now unearthing them. Writing in a special issu...
(Date:12/3/2008)...they may not help improve a person,s golf game, st...k about the local country club in the near future,... "There are more than 17,000 golf courses in the U... land is not used for playing," said Ray Semlitsch... of Arts and Science. "These managed green spaces ...
(Date:12/3/2008)... trials that individuals can respond just as well ...On the other hand, it is difficult to explain why ...eam of researchers from Uppsala University and Got...at can impact the placebo effect and a mechanism i...o placebos. , The study, published in Journal o...
Breaking Biology News(10 mins):Myth about 'dirty old men' supported by science 2Researchers examine role of soil patterns in dam restoration 2Researchers examine role of soil patterns in dam restoration 3Golf course: Playing fields, wildlife sanctuaries or both 2Genes determine whether sugar pills work 2Kiwa Bio Tech 2nd Quarter Revenues Increase 61 7 25 to 243 Million Six Month Revenues Top 245 2 Million 7080 1Kiwa Bio Tech 2nd Quarter Revenues Increase 61 7 25 to 243 Million Six Month Revenues Top 245 2 Million 7080 2Kiwa Bio Tech 2nd Quarter Revenues Increase 61 7 25 to 243 Million Six Month Revenues Top 245 2 Million 7080 3Kiwa Bio Tech 2nd Quarter Revenues Increase 61 7 25 to 243 Million Six Month Revenues Top 245 2 Million 7080 4Kiwa Bio Tech 2nd Quarter Revenues Increase 61 7 25 to 243 Million Six Month Revenues Top 245 2 Million 7080 5Kiwa Bio Tech 2nd Quarter Revenues Increase 61 7 25 to 243 Million Six Month Revenues Top 245 2 Million 7080 6Kiwa Bio Tech 2nd Quarter Revenues Increase 61 7 25 to 243 Million Six Month Revenues Top 245 2 Million 7080 7Kiwa Bio Tech 2nd Quarter Revenues Increase 61 7 25 to 243 Million Six Month Revenues Top 245 2 Million 7080 8Kiwa Bio Tech 2nd Quarter Revenues Increase 61 7 25 to 243 Million Six Month Revenues Top 245 2 Million 7080 9Ethicon Endo Surgery to Acquire SurgRx 7075 1Ethicon Endo Surgery to Acquire SurgRx 7075 2Ethicon Endo Surgery to Acquire SurgRx 7075 3Lack of Vitamin D Boosts Death Risk 25272 1Lack of Vitamin D Boosts Death Risk 25272 2Lack of Vitamin D Boosts Death Risk 25272 3Research translates into successful community practice to improve elder health 25267 1Research translates into successful community practice to improve elder health 25267 2
....,announced plans to make eight new GeneChip(R) pl...part of its Consortia Program, including,canine, R...ica, tomato,citrus, poplar and sugar cane. More t... and Animal Genome Conference XIII in San Diego,C...nder the Consortia,Program. , Some of the studies ...
...ability of,HIV infection per act of heterosexual s...s has found that uncircumcised men have more,than ...d men.,In the study, published in the Feb. 15 issu...able online, Jared Baeten and colleagues,from the ...data from a,group of male Kenyan truckers and, usi...
...ng,nanoparticle and gene silencing technologies th... -- a virus associated with severe,bronchitis and ...rida,researchers found. The study was reported in ...ine.,RSV infects lung cells and can be life-threat...e with compromised immune systems. No,vaccine or w...
... replicated hepatitis C virus (HCV) in the laborat...will allow researchers to better study the life cy...l antiviral compounds, which may lead to new thera...tion with HCV. Scientists at the National Institut...IDDK), one of the National Institutes of Health (N...
Other Biology News:Affymetrix Unveils Plans to Double Plant and Animal Genome Microarray Offering 2Male circumcision reduces risk of HIV transmission from women to men 2Novel antiviral technology inhibits RSV infection in mice 2Scientists Replicate Hepatitis C Virus in Laboratory 2
Bovine Brain Microvascular Endothelial Cells (BBMVEC) (>500,000 cells)
The improved design and new mechanical solutions of Finnpipette Focus Multichannel Plus improves accuracy and precision.In these low volume multichannel pipettes, the super blow-out function ensures
...ueous solution. Cleaves a-(1-3)- and a(1-6)-lin...carbohydrates and glycoproteins. It is particularl...conditions where the pH must be neutral or above, ... One unit will hydrolyze 1 mole of p-nitrophenyl a...
...for human cardiac troponin subunit T, a 31kDa prot...s responsible for contraction of cardiac muscle. I... human cells. It also cross-reacts with human skel...hly purified human cardiac troponin T This antib...
Biology Products: